# Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial

Study · id `cardio:ct-nct02175225` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02175225](<https://clinicaltrials.gov/study/NCT02175225>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02175225

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 294 participants.

## Technical summary

Registry record NCT02175225. Randomized; quadruple masking; primary purpose treatment. Start 2014-10 (actual); primary completion 2018-02-10 (actual). Results posted on 2019-05-30.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 294 participants (enrolled count; ClinicalTrials.gov record NCT02175225, source copy `cardio:ctgov-nct02175225-2019-05-30`, retrieved 2026-10-31)
- Started: 2014-10 (actual) (ClinicalTrials.gov record NCT02175225, source copy `cardio:ctgov-nct02175225-2019-05-30`, retrieved 2026-10-31)
- Primary completion: 2018-02-10 (actual) (ClinicalTrials.gov record NCT02175225, source copy `cardio:ctgov-nct02175225-2019-05-30`, retrieved 2026-10-31)
- Completion: 2018-05-30 (actual) (ClinicalTrials.gov record NCT02175225, source copy `cardio:ctgov-nct02175225-2019-05-30`, retrieved 2026-10-31)
- Results first posted: 2019-05-30 (ClinicalTrials.gov record NCT02175225, source copy `cardio:ctgov-nct02175225-2019-05-30`, retrieved 2026-10-31)
- Countries: United States; Canada (ClinicalTrials.gov record NCT02175225, source copy `cardio:ctgov-nct02175225-2019-05-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02175225-2019-05-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
- Condition: Intracerebral Hemorrhage
- Intervention (Drug): Deferoxamine Mesylate
- Intervention (Drug): Placebo (for Deferoxamine Mesylate)
- Lead sponsor: Beth Israel Deaconess Medical Center
- Lead sponsor class: OTHER
- Collaborator: Medical University of South Carolina
- Collaborator class: OTHER
- Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator class: NIH
- Collaborator: Massachusetts General Hospital
- Collaborator class: OTHER
- Collaborator: University of Massachusetts, Worcester
- Collaborator class: OTHER
- Collaborator: University of Pennsylvania
- Collaborator class: OTHER
- Collaborator: Johns Hopkins University
- Collaborator class: OTHER
- Collaborator: Duke University
- Collaborator class: OTHER
- Collaborator: University of North Carolina
- Collaborator class: OTHER
- Collaborator: University of Florida
- Collaborator class: OTHER
- Collaborator: Henry Ford Hospital
- Collaborator class: OTHER
- Collaborator: Ohio State University
- Collaborator class: OTHER
- Collaborator: St. Joseph's Hospital and Medical Center, Phoenix
- Collaborator class: OTHER
- Collaborator: University of California, San Francisco
- Collaborator class: OTHER
- Collaborator: Oregon Health and Science University
- Collaborator class: OTHER
- Collaborator: Yale New Haven Health System Center for Healthcare Solutions
- Collaborator class: OTHER
- Collaborator: University of Iowa
- Collaborator class: OTHER
- Collaborator: Hartford Hospital
- Collaborator class: OTHER
- Collaborator: The University of Texas Health Science Center, Houston
- Collaborator class: OTHER
- Collaborator: Rhode Island Hospital
- Collaborator class: OTHER
- Collaborator: Stanford University
- Collaborator class: OTHER
- Collaborator: University of Washington
- Collaborator class: OTHER
- Collaborator: University of Calgary
- Collaborator class: OTHER
- Collaborator: Hopital de l'Enfant-Jesus
- Collaborator class: OTHER
- Collaborator: University of Alberta
- Collaborator class: OTHER
- Collaborator: Rush University Medical Center
- Collaborator class: OTHER
- Collaborator: University Hospitals Cleveland Medical Center
- Collaborator class: OTHER
- Collaborator: Columbia University
- Collaborator class: OTHER
- Collaborator: Weill Medical College of Cornell University
- Collaborator class: OTHER
- Collaborator: NYU Langone Health
- Collaborator class: OTHER
- Collaborator: Mount Sinai Hospital, New York
- Collaborator class: OTHER
- Collaborator: Loyola University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry lists this organization as a collaborator: National Institute of Neurological Disorders and Stroke (`cardio:ninds`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial (`cardio:pubmed-30898550`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Deferoxamine on Trajectory of Recovery After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial (`cardio:pubmed-35306827`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The Prognostic Roles of Perihematomal Edema and Ventricular Size in Patients with Intracerebral Hemorrhage (`cardio:pubmed-35676589`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Early neurological improvement with deferoxamine after intracerebral hemorrhage: A post hoc analysis of the i-DEF trial (`cardio:pubmed-40418029`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Evolution of Perihematomal Edema Mean Hounsfield Unit and Its Association with Clinical Outcome in Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial (`cardio:pubmed-40789806`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Hemoglobin and Perihematomal Edema After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial (`cardio:pubmed-40399657`)

Courtesy of the U.S. National Library of Medicine.

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 27 registry organizations

## Provenance

Content hash: 58254cc52d0eeead938d7e641ee541e3e18c755421146f10d3332d0da5aaf03c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
